Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-06-26 | New | $765,000 | $765,000 | Debt Only | 06b | SEC link |
| 2023-03-17 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2022-04-15 | New | $5,000,000 | $5,000,000 | Debt Only | 06b | SEC link |
| 2020-09-02 | New | $1,500,000 | $1,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Maryann Bryla | Director |
| Amar Kapur | Director |
| James Larrick | Director |
| Randall Marshall | Executive |
| Kim Patrick | Director |
| Andrew Pearlman | Director |
| Mark Tepper | Director, Executive |